| Product NDC: | 52544-884 |
| Proprietary Name: | Alora |
| Non Proprietary Name: | Estradiol Transdermal System |
| Active Ingredient(s): | .025 mg/d & nbsp; Estradiol Transdermal System |
| Administration Route(s): | TRANSDERMAL |
| Dosage Form(s): | PATCH |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52544-884 |
| Labeler Name: | Watson Pharma, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020655 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20020405 |
| Package NDC: | 52544-884-08 |
| Package Description: | 8 POUCH in 1 BOX (52544-884-08) > 1 PATCH in 1 POUCH > 3.5 d in 1 PATCH |
| NDC Code | 52544-884-08 |
| Proprietary Name | Alora |
| Package Description | 8 POUCH in 1 BOX (52544-884-08) > 1 PATCH in 1 POUCH > 3.5 d in 1 PATCH |
| Product NDC | 52544-884 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Estradiol Transdermal System |
| Dosage Form Name | PATCH |
| Route Name | TRANSDERMAL |
| Start Marketing Date | 20020405 |
| Marketing Category Name | NDA |
| Labeler Name | Watson Pharma, Inc. |
| Substance Name | ESTRADIOL |
| Strength Number | .025 |
| Strength Unit | mg/d |
| Pharmaceutical Classes | Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |